Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,000 35 40 35 40 B-lower_bound
mm^3 41 45 41 45 I-lower_bound
Platelet 46 54 46 54 B-clinical_variable
count 55 60 55 60 I-clinical_variable
> 61 62 61 62 O
= 62 63 62 63 O
75,000 64 70 64 70 B-lower_bound
/ 70 71 70 71 I-lower_bound
mm^3 71 75 71 75 I-lower_bound

Active 0 6 76 82 O
hepatitis 7 16 83 92 B-chronic_disease
A 17 18 93 94 I-chronic_disease
, 18 19 94 95 I-chronic_disease
B 20 21 96 97 I-chronic_disease
or 22 24 98 100 I-chronic_disease
C 25 26 101 102 I-chronic_disease
virus 27 32 103 108 B-chronic_disease
infection 33 42 109 118 I-chronic_disease
, 42 43 118 119 O
or 44 46 120 122 O
known 47 52 123 128 O
human 53 58 129 134 B-chronic_disease
immunodeficiency 59 75 135 151 I-chronic_disease
virus 76 81 152 157 I-chronic_disease
( 82 83 158 159 I-chronic_disease
HIV 83 86 159 162 I-chronic_disease
) 86 87 162 163 I-chronic_disease
positive 88 96 164 172 O

Administration 0 14 173 187 O
or 15 17 188 190 O
planned 18 25 191 198 O
administration 26 40 199 213 O
of 41 43 214 216 O
any 44 47 217 220 O
other 48 53 221 226 O
concomitant 54 65 227 238 O
chemotherapy 66 78 239 251 B-treatment
, 78 79 251 252 O
immunotherapy 80 93 253 266 B-treatment
, 93 94 266 267 O
radiotherapy 95 107 268 280 B-treatment
, 107 108 280 281 O
or 109 111 282 284 O
any 112 115 285 288 O
ancillary 116 125 289 298 B-treatment
therapy 126 133 299 306 I-treatment
which 134 139 307 312 O
would 140 145 313 318 O
be 146 148 319 321 O
considered 149 159 322 332 O
a 160 161 333 334 O
treatment 162 171 335 344 B-treatment
of 172 174 345 347 O
multiple 175 183 348 356 B-cancer
myeloma 184 191 357 364 I-cancer
until 192 197 365 370 O
Day 198 201 371 374 O
+28 202 205 375 378 O
post 206 210 379 383 B-treatment
- 210 211 383 384 I-treatment
transplant 211 221 384 394 I-treatment
through 222 229 395 402 O
discontinuation 230 245 403 418 O
from 246 250 419 423 O
study 251 256 424 429 O

All 0 3 430 433 O
patients 4 12 434 442 O
must 13 17 443 447 O
be 18 20 448 450 O
counseled 21 30 451 460 O
at 31 33 461 463 O
a 34 35 464 465 O
minimum 36 43 466 473 O
of 44 46 474 476 O
every 47 52 477 482 O
28 53 55 483 485 B-lower_bound
days 56 60 486 490 I-lower_bound
about 61 66 491 496 O
pregnancy 67 76 497 506 B-pregnancy
precautions 77 88 507 518 O
and 89 92 519 522 O
risks 93 98 523 528 O
of 99 101 529 531 O
fetal 102 107 532 537 O
exposure 108 116 538 546 O

Any 0 3 547 550 O
serious 4 11 551 558 O
medical 12 19 559 566 B-chronic_disease
or 20 22 567 569 O
psychiatric 23 34 570 581 B-chronic_disease
illness 35 42 582 589 I-chronic_disease
that 43 47 590 594 O
could 48 53 595 600 O
, 53 54 600 601 O
in 55 57 602 604 O
the 58 61 605 608 O
investigator 62 74 609 621 O
's 74 76 621 623 O
opinion 77 84 624 631 O
, 84 85 631 632 O
potentially 86 97 633 644 O
interfere 98 107 645 654 O
with 108 112 655 659 O
the 113 116 660 663 O
completion 117 127 664 674 O
of 128 130 675 677 O
treatment 131 140 678 687 B-treatment
according 141 150 688 697 O
to 151 153 698 700 O
this 154 158 701 705 O
protocol 159 167 706 714 O

Between 0 7 715 722 O
the 8 11 723 726 O
ages 12 16 727 731 B-age
of 17 19 732 734 O
18 20 22 735 737 B-lower_bound
and 23 26 738 741 O
70 27 29 742 744 B-upper_bound
years 30 35 745 750 I-upper_bound
of 36 38 751 753 O
age 39 42 754 757 O
( 43 44 758 759 O
inclusive 44 53 759 768 O
) 53 54 768 769 O
at 55 57 770 772 O
time 58 62 773 777 O
of 63 65 778 780 O
enrollment 66 76 781 791 O

Cardiac 0 7 792 799 B-chronic_disease
syncope 8 15 800 807 I-chronic_disease

Concurrent 0 10 808 818 O
hematologic 11 22 819 830 B-cancer
or 23 25 831 833 O
non 26 29 834 837 B-cancer
- 29 30 837 838 I-cancer
hematologic 30 41 838 849 I-cancer
malignancy 42 52 850 860 I-cancer
requiring 53 62 861 870 O
treatment 63 72 871 880 B-treatment

Eastern 0 7 881 888 B-clinical_variable
Cooperative 8 19 889 900 I-clinical_variable
Oncology 20 28 901 909 I-clinical_variable
Group 29 34 910 915 I-clinical_variable
( 35 36 916 917 I-clinical_variable
ECOG 36 40 917 921 I-clinical_variable
) 40 41 921 922 I-clinical_variable
performance 42 53 923 934 I-clinical_variable
status 54 60 935 941 I-clinical_variable
and/or 61 67 942 948 O
other 68 73 949 954 O
performance 74 85 955 966 O
status 86 92 967 973 O
0 93 94 974 975 O
, 94 95 975 976 O
1 96 97 977 978 O
, 97 98 978 979 O
or 99 101 980 982 O

Evidence 0 8 983 991 O
of 9 11 992 994 O
MM 12 14 995 997 B-cancer
disease 15 22 998 1005 O
progression 23 34 1006 1017 O
any 35 38 1018 1021 O
time 39 43 1022 1026 O
prior 44 49 1027 1032 O
to 50 52 1033 1035 O
enrollment 53 63 1036 1046 O

Female 0 6 1047 1053 B-gender
patients 7 15 1054 1062 I-gender
who 16 19 1063 1066 O
are 20 23 1067 1070 O
lactating 24 33 1071 1080 O
or 34 36 1081 1083 O
have 37 41 1084 1088 O
a 42 43 1089 1090 O
positive 44 52 1091 1099 B-pregnancy
serum 53 58 1100 1105 I-pregnancy
pregnancy 59 68 1106 1115 I-pregnancy
test 69 73 1116 1120 O
during 74 80 1121 1127 O
the 81 84 1128 1131 O
screening 85 94 1132 1141 O
period 95 101 1142 1148 O

Grade 0 5 1149 1154 B-clinical_variable
> 6 7 1155 1156 O
= 7 8 1156 1157 O
3 9 10 1158 1159 O
peripheral 11 21 1160 1170 O
neuropathy 22 32 1171 1181 O

Histologically 0 14 1182 1196 O
confirmed 15 24 1197 1206 O
diagnosis 25 34 1207 1216 O
of 35 37 1217 1219 O
symptomatic 38 49 1220 1231 O
multiple 50 58 1232 1240 B-cancer
myeloma 59 66 1241 1248 I-cancer

History 0 7 1249 1256 O
of 8 10 1257 1259 O
plasma 11 17 1260 1266 B-cancer
cell 18 22 1267 1271 I-cancer
leukemia 23 31 1272 1280 I-cancer
or 32 34 1281 1283 O
MM 35 37 1284 1286 B-cancer
CNS 38 41 1287 1290 I-cancer
involvement 42 53 1291 1302 O

Infection 0 9 1303 1312 B-chronic_disease
requiring 10 19 1313 1322 O
systemic 20 28 1323 1331 B-treatment
antibiotic 29 39 1332 1342 I-treatment
therapy 40 47 1343 1350 I-treatment
or 48 50 1351 1353 O
other 51 56 1354 1359 O
serious 57 64 1360 1367 O
infection 65 74 1368 1377 B-chronic_disease
within 75 81 1378 1384 O
14 82 84 1385 1387 B-upper_bound
days 85 89 1388 1392 I-upper_bound
prior 90 95 1393 1398 I-upper_bound
to 96 98 1399 1401 O
start 99 104 1402 1407 O
of 105 107 1408 1410 O
study 108 113 1411 1416 O
treatment 114 123 1417 1426 B-treatment

Known 0 5 1427 1432 O
GI 6 8 1433 1435 B-chronic_disease
disease 9 16 1436 1443 I-chronic_disease
or 17 19 1444 1446 O
GI 20 22 1447 1449 B-treatment
procedure 23 32 1450 1459 I-treatment
that 33 37 1460 1464 O
could 38 43 1465 1470 O
interfere 44 53 1471 1480 O
with 54 58 1481 1485 O
the 59 62 1486 1489 O
oral 63 67 1490 1494 O
absorption 68 78 1495 1505 O
or 79 81 1506 1508 O
tolerance 82 91 1509 1518 O
of 92 94 1519 1521 O
ixazomib 95 103 1522 1530 B-treatment

Known 0 5 1531 1536 O
allergy 6 13 1537 1544 O
to 14 16 1545 1547 O
any 17 20 1548 1551 O
of 21 23 1552 1554 O
the 24 27 1555 1558 O
study 28 33 1559 1564 B-allergy_name
medications 34 45 1565 1576 I-allergy_name
, 45 46 1576 1577 O
their 47 52 1578 1583 O
analogues 53 62 1584 1593 O
, 62 63 1593 1594 O
or 64 66 1595 1597 O
excipients 67 77 1598 1608 O
in 78 80 1609 1611 O
the 81 84 1612 1615 O
various 85 92 1616 1623 O
formulations 93 105 1624 1636 O
of 106 108 1637 1639 O
any 109 112 1640 1643 O
agent 113 118 1644 1649 O

Major 0 5 1650 1655 B-treatment
surgery 6 13 1656 1663 I-treatment
within 14 20 1664 1670 O
14 21 23 1671 1673 B-upper_bound
days 24 28 1674 1678 I-upper_bound
prior 29 34 1679 1684 I-upper_bound
to 35 37 1685 1687 O
start 38 43 1688 1693 O
of 44 46 1694 1696 O
study 47 52 1697 1702 O
treatment 53 62 1703 1712 B-treatment

Participation 0 13 1713 1726 O
in 14 16 1727 1729 O
other 17 22 1730 1735 O
clinical 23 31 1736 1744 B-treatment
trials 32 38 1745 1751 I-treatment
, 38 39 1751 1752 O
including 40 49 1753 1762 O
those 50 55 1763 1768 O
with 56 60 1769 1773 O
other 61 66 1774 1779 O
investigational 67 82 1780 1795 B-treatment
agents 83 89 1796 1802 I-treatment
not 90 93 1803 1806 O
included 94 102 1807 1815 O
in 103 105 1816 1818 O
this 106 110 1819 1823 O
trial 111 116 1824 1829 O
, 116 117 1829 1830 O
within 118 124 1831 1837 O
30 125 127 1838 1840 B-upper_bound
days 128 132 1841 1845 I-upper_bound
prior 133 138 1846 1851 I-upper_bound
to 139 141 1852 1854 O
start 142 147 1855 1860 O
of 148 150 1861 1863 O
study 151 156 1864 1869 B-treatment
treatment 157 166 1870 1879 I-treatment
and 167 170 1880 1883 O
throughout 171 181 1884 1894 O
the 182 185 1895 1898 O
duration 186 194 1899 1907 O
of 195 197 1908 1910 O
this 198 202 1911 1915 O
trial 203 208 1916 1921 O

Patients 0 8 1922 1930 O
may 9 12 1931 1934 O
be 13 15 1935 1937 O
on 16 18 1938 1940 O
corticosteroids 19 34 1941 1956 B-treatment
if 35 37 1957 1959 O
they 38 42 1960 1964 O
are 43 46 1965 1968 O
being 47 52 1969 1974 O
given 53 58 1975 1980 O
for 59 62 1981 1984 O
disorders 63 72 1985 1994 O
other 73 78 1995 2000 O
than 79 83 2001 2005 O
multiple 84 92 2006 2014 B-cancer
myeloma 93 100 2015 2022 I-cancer
( 101 102 2023 2024 O
e.g. 102 106 2024 2028 O
, 106 107 2028 2029 O
adrenal 108 115 2030 2037 B-chronic_disease
insufficiency 116 129 2038 2051 I-chronic_disease
, 129 130 2051 2052 O
rheumatoid 131 141 2053 2063 B-chronic_disease
arthritis 142 151 2064 2073 I-chronic_disease
, 151 152 2073 2074 O
etc 153 156 2075 2078 O
. 156 157 2078 2079 O
) 157 158 2079 2080 O

Patients 0 8 2081 2089 O
with 9 13 2090 2094 O
multiple 14 22 2095 2103 O
myeloma 23 30 2104 2111 B-cancer
with 31 35 2112 2116 O
secondary 36 45 2117 2126 O
amyloidosis 46 57 2127 2138 B-chronic_disease

Per 0 3 2139 2142 O
standard 4 12 2143 2151 O
Revlimid 13 21 2152 2160 B-treatment
REMS 22 26 2161 2165 I-treatment
program 27 34 2166 2173 I-treatment
requirements 35 47 2174 2186 O
, 47 48 2186 2187 O
all 49 52 2188 2191 O
physicians 53 63 2192 2202 O
who 64 67 2203 2206 O
prescribe 68 77 2207 2216 O
lenalidomide 78 90 2217 2229 B-treatment
for 91 94 2230 2233 O
research 95 103 2234 2242 O
subjects 104 112 2243 2251 O
enrolled 113 121 2252 2260 O
into 122 126 2261 2265 O
this 127 131 2266 2270 O
trial 132 137 2271 2276 O
, 137 138 2276 2277 O
must 139 143 2278 2282 O
be 144 146 2283 2285 O
registered 147 157 2286 2296 O
in 158 160 2297 2299 O
, 160 161 2299 2300 O
and 162 165 2301 2304 O
must 166 170 2305 2309 O
comply 171 177 2310 2316 O
with 178 182 2317 2321 O
, 182 183 2321 2322 O
all 184 187 2323 2326 O
requirements 188 200 2327 2339 O
of 201 203 2340 2342 O
the 204 207 2343 2346 O
Revlimid 208 216 2347 2355 O
REMS 217 221 2356 2360 O
program 222 229 2361 2368 O

Prior 0 5 2369 2374 B-treatment
organ 6 11 2375 2380 I-treatment
transplant 12 22 2381 2391 I-treatment
requiring 23 32 2392 2401 O
immunosuppressive 33 50 2402 2419 B-treatment
therapy 51 58 2420 2427 I-treatment

Progression 0 11 2428 2439 O
from 12 16 2440 2444 O
smoldering 17 27 2445 2455 O
/ 27 28 2455 2456 O
asymptomatic 28 40 2456 2468 O
MM 41 43 2469 2471 B-cancer
to 44 46 2472 2474 O
symptomatic 47 58 2475 2486 O
MM 59 61 2487 2489 O

Received 0 8 2490 2498 O
at 9 11 2499 2501 O
least 12 17 2502 2507 O
two 18 21 2508 2511 B-lower_bound
cycles 22 28 2512 2518 O
of 29 31 2519 2521 O
any 32 35 2522 2525 O
regimen 36 43 2526 2533 B-treatment
as 44 46 2534 2536 O
initial 47 54 2537 2544 O
systemic 55 63 2545 2553 B-treatment
therapy 64 71 2554 2561 I-treatment
for 72 75 2562 2565 O
multiple 76 84 2566 2574 B-cancer
myeloma 85 92 2575 2582 I-cancer
and 93 96 2583 2586 O
are 97 100 2587 2590 O
within 101 107 2591 2597 O
2 108 109 2598 2599 B-lower_bound
- 109 110 2599 2600 O
16 110 112 2600 2602 B-upper_bound
months 113 119 2603 2609 I-upper_bound
of 120 122 2610 2612 O
the 123 126 2613 2616 O
first 127 132 2617 2622 O
dose 133 137 2623 2627 O
of 138 140 2628 2630 O
initial 141 148 2631 2638 B-treatment
therapy 149 156 2639 2646 I-treatment

Should 0 6 2647 2653 O
a 7 8 2654 2655 O
woman 9 14 2656 2661 B-gender
become 15 21 2662 2668 O
pregnant 22 30 2669 2677 B-pregnancy
or 31 33 2678 2680 O
suspect 34 41 2681 2688 B-pregnancy
she 42 45 2689 2692 I-pregnancy
is 46 48 2693 2695 I-pregnancy
pregnant 49 57 2696 2704 I-pregnancy
while 58 63 2705 2710 O
participating 64 77 2711 2724 O
in 78 80 2725 2727 O
this 81 85 2728 2732 O
study 86 91 2733 2738 O
, 91 92 2738 2739 O
she 93 96 2740 2743 O
must 97 101 2744 2748 O
inform 102 108 2749 2755 O
her 109 112 2756 2759 O
treating 113 121 2760 2768 O
physician 122 131 2769 2778 O
immediately 132 143 2779 2790 O

Tandem 0 6 2791 2797 B-treatment
autologous 7 17 2798 2808 I-treatment
transplantation 18 33 2809 2824 I-treatment

This 0 4 2825 2829 O
is 5 7 2830 2832 O
defined 8 15 2833 2840 O
as 16 18 2841 2843 O
either 19 25 2844 2850 O
committing 26 36 2851 2861 B-contraception_consent
to 37 39 2862 2864 I-contraception_consent
continued 40 49 2865 2874 I-contraception_consent
abstinence 50 60 2875 2885 I-contraception_consent
from 61 65 2886 2890 I-contraception_consent
heterosexual 66 78 2891 2903 I-contraception_consent
intercourse 79 90 2904 2915 I-contraception_consent
or 91 93 2916 2918 I-contraception_consent
beginning 94 103 2919 2928 I-contraception_consent
TWO 104 107 2929 2932 I-contraception_consent
acceptable 108 118 2933 2943 I-contraception_consent
methods 119 126 2944 2951 I-contraception_consent
of 127 129 2952 2954 I-contraception_consent
contraception 130 143 2955 2968 I-contraception_consent
( 144 145 2969 2970 O
one 145 148 2970 2973 O
highly 149 155 2974 2980 O
effective 156 165 2981 2990 O
method 166 172 2991 2997 O
and 173 176 2998 3001 O
one 177 180 3002 3005 O
additional 181 191 3006 3016 O
effective 192 201 3017 3026 O
method 202 208 3027 3033 O
AT 209 211 3034 3036 O
THE 212 215 3037 3040 O
SAME 216 220 3041 3045 O
TIME 221 225 3046 3050 O
) 225 226 3050 3051 O
at 227 229 3052 3054 O
least 230 235 3055 3060 O
28 236 238 3061 3063 B-upper_bound
days 239 243 3064 3068 I-upper_bound
prior 244 249 3069 3074 I-lower_bound
to 250 252 3075 3077 O
the 253 256 3078 3081 O
start 257 262 3082 3087 O
of 263 265 3088 3090 O
lenalidomide 266 278 3091 3103 B-treatment
, 278 279 3103 3104 O
for 280 283 3105 3108 O
the 284 287 3109 3112 O
duration 288 296 3113 3121 O
of 297 299 3122 3124 O
study 300 305 3125 3130 O
participation 306 319 3131 3144 O
, 319 320 3144 3145 O
and 321 324 3146 3149 O
for 325 328 3150 3153 O
28 329 331 3154 3156 O
days 332 336 3157 3161 O
following 337 346 3162 3171 O
the 347 350 3172 3175 O
last 351 355 3176 3180 O
dose 356 360 3181 3185 O
of 361 363 3186 3188 O
lenalidomide 364 376 3189 3201 O

Women 0 5 3202 3207 B-gender
of 6 8 3208 3210 O
childbearing 9 21 3211 3223 O
potential 22 31 3224 3233 O
must 32 36 3234 3238 O
also 37 41 3239 3243 O
agree 42 47 3244 3249 O
to 48 50 3250 3252 O
ongoing 51 58 3253 3260 O
pregnancy 59 68 3261 3270 B-pregnancy
testing 69 76 3271 3278 O

Women 0 5 3279 3284 B-gender
of 6 8 3285 3287 O
childbearing 9 21 3288 3300 O
potential 22 31 3301 3310 O
must 32 36 3311 3315 O
follow 37 43 3316 3322 O
pregnancy 44 53 3323 3332 B-pregnancy
testing 54 61 3333 3340 O
requirements 62 74 3341 3353 O
as 75 77 3354 3356 O
outlined 78 86 3357 3365 O
in 87 89 3366 3368 O
the 90 93 3369 3372 O
Revlimid 94 102 3373 3381 O
REMS 103 107 3382 3386 O
program 108 115 3387 3394 O
material 116 124 3395 3403 O

clinically 0 10 3404 3414 O
important 11 20 3415 3424 O
autonomic 21 30 3425 3434 B-chronic_disease
disease 31 38 3435 3442 I-chronic_disease

clinically 0 10 3443 3453 O
significant 11 22 3454 3465 O
repetitive 23 33 3466 3476 O
ventricular 34 45 3477 3488 B-chronic_disease
arrhythmias 46 57 3489 3500 I-chronic_disease
despite 58 65 3501 3508 O
antiarrhythmic 66 80 3509 3523 B-treatment
treatment 81 90 3524 3533 I-treatment

multiple 0 8 3534 3542 B-cancer
myeloma 9 16 3543 3550 I-cancer

myocardial 0 10 3551 3561 B-chronic_disease
infarction 11 21 3562 3572 I-chronic_disease
within 22 28 3573 3579 O
the 29 32 3580 3583 O
previous 33 41 3584 3592 B-upper_bound
six 42 45 3593 3596 I-upper_bound
months 46 52 3597 3603 I-upper_bound

secondary 0 9 3604 3613 B-chronic_disease
amyloidosis 10 21 3614 3625 I-chronic_disease

severe 0 6 3626 3632 O
orthostatic 7 18 3633 3644 B-chronic_disease
hypotension 19 30 3645 3656 I-chronic_disease

uncompensated 0 13 3657 3670 O
NYHA 14 18 3671 3675 B-clinical_variable
Class 19 24 3676 3681 B-lower_bound
3 25 26 3682 3683 I-lower_bound
or 27 29 3684 3686 O
4 30 31 3687 3688 B-upper_bound
congestive 32 42 3689 3699 B-chronic_disease
heart 43 48 3700 3705 I-chronic_disease
failure 49 56 3706 3713 I-chronic_disease

unstable 0 8 3714 3722 B-chronic_disease
angina 9 15 3723 3729 I-chronic_disease
pectoris 16 24 3730 3738 I-chronic_disease

